Khirurgiia · 2026
[Packed red blood cell transfusions in perioperative period in patients with gastrointestinal malignancies].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sazhin A V, Kumukova I B, Ermakov I V, Dalgatov K D, Mamedov E A
Аннотация
OBJECTIVE: To compare the incidence of postoperative complications in patients with gastrointestinal cancer and anemia depending on red blood cell transfusion.
MATERIAL AND METHODS: We analyzed treatment outcomes in patients with anemia who underwent surgery between 01.01.2022 and 30.01.2024. The main group included 105 patients who received red blood cell transfusions, the control group - 124 patients without transfusions. We assessed postoperative complications according to the Clavien-Dindo classification, length of hospital stay, readmission, 30-day and 90-day mortality.
RESULTS: The study included 229 patients. Transfusions were performed in 105 (45.9%) patients, and there were no transfusions in 124 (54.1%) patients. Postoperative complications were more common in patients with transfusions (26.6% vs. 45.7%, p=0.003) (mainly Clavien-Dindo grade II (15.3% vs. 36.2%, p<0.001) and grade V (0% vs. 7.6%, p=0.002)). In patients with transfusions, hospital stay was 14 days, without transfusion - 11 days (p=0.001). Readmission rate (0% versus 14.3%, p<0.001), 30-day (0% and 6.7%, p=0.004) and 90-day mortality (0% and 11.4%, p<0.001) were higher in the transfusion group.
CONCLUSION: Correction of anemia with red blood cell transfusions in patients with gastrointestinal cancer increases the incidence of postoperative complications, length of hospital stay, readmission rate, 30-day and 90-day mortality.
MATERIAL AND METHODS: We analyzed treatment outcomes in patients with anemia who underwent surgery between 01.01.2022 and 30.01.2024. The main group included 105 patients who received red blood cell transfusions, the control group - 124 patients without transfusions. We assessed postoperative complications according to the Clavien-Dindo classification, length of hospital stay, readmission, 30-day and 90-day mortality.
RESULTS: The study included 229 patients. Transfusions were performed in 105 (45.9%) patients, and there were no transfusions in 124 (54.1%) patients. Postoperative complications were more common in patients with transfusions (26.6% vs. 45.7%, p=0.003) (mainly Clavien-Dindo grade II (15.3% vs. 36.2%, p<0.001) and grade V (0% vs. 7.6%, p=0.002)). In patients with transfusions, hospital stay was 14 days, without transfusion - 11 days (p=0.001). Readmission rate (0% versus 14.3%, p<0.001), 30-day (0% and 6.7%, p=0.004) and 90-day mortality (0% and 11.4%, p<0.001) were higher in the transfusion group.
CONCLUSION: Correction of anemia with red blood cell transfusions in patients with gastrointestinal cancer increases the incidence of postoperative complications, length of hospital stay, readmission rate, 30-day and 90-day mortality.